Medpace Holdings, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.5B | $2.1B | $1.9B | $1.5B | $1.1B |
| Selling, general & administrative | $197.6M | $180.2M | $161.4M | $131.4M | $108.4M |
| Operating income | $534.9M | $446.9M | $336.8M | $278.7M | $198.6M |
| Pretax income | $542.4M | $475.9M | $335.7M | $282.9M | $201.9M |
| Income tax expense | $91.3M | $71.5M | $52.9M | $37.5M | $20.0M |
| Net income | $451.1M | $404.4M | $282.8M | $245.4M | $181.8M |
| Balance Sheet | |||||
| Cash and equivalents | $497.0M | $669.4M | $245.4M | $28.3M | $461.3M |
| Current assets | $989.6M | $1.0B | $593.8M | $334.0M | $690.9M |
| Total assets | $2.0B | $2.1B | $1.7B | $1.4B | $1.7B |
| Current liabilities | $1.3B | $1.1B | $925.1M | $803.5M | $557.2M |
| Total liabilities | $1.5B | $1.3B | $1.1B | $966.1M | $707.0M |
| Stockholders' equity | $459.1M | $825.5M | $559.0M | $386.4M | $952.9M |
| Cash Flow Statement | |||||
| Cash from operations | $713.2M | $608.8M | $433.4M | $388.1M | $263.3M |
| Depreciation and amortization | $27.2M | $27.8M | $24.1M | $19.0M | $16.0M |
| Stock-based compensation | $34.8M | $25.5M | $20.5M | $21.4M | $14.5M |
| Capital expenditure | $31.4M | $36.5M | $36.6M | $36.9M | $28.3M |
| Free cash flow | $681.9M | $572.3M | $396.7M | $351.2M | $235.1M |
| Share repurchases | $917.4M | $169.9M | $144.0M | $847.8M | $62.1M |
Shares outstanding 28.6M · Free float 59.3%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.